NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Fox News legal editor Kerri Urbahn and ‘The Fixer’ host Marcus Lemonis join ‘The Faulkner Focus’ to discuss the Supreme Court’s decision to rule against President Donald Trump’s global tariffs.Read More